Search
for

    Sort by

    Research 421–450 of 1000+

    1. Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management Multiple Sclerosis Journal · 2004 · 37 citations
    2. Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety Dermatology Practical & Conceptual · 2024 · 2 citations
    3. Update on Hidradenitis Suppurativa (Part I): Epidemiology, Pathogenesis, Severity assessment and Comorbidities Revista da Sociedade Portuguesa de Dermatologia e Venereologia · 2018 · 1 citations
    4. Ayurveda-Based Supportive Care Using Guduchi, Ashwagandha, and Curcumin for Breast Cancer Patients: A Pilot Observational Study on Quality of Life and Safety 2025
    5. Formulation and Evaluation of a Polyherbal Hair Dye Containing Phyllanthus reticulatus Fruit Extract: Physicochemical, Antioxidant, Antimicrobial and Stability Assessment International Journal of Research Publication and Reviews · 2026
    6. Green chemistry in hair care: A review on the formulation, efficacy, and safety profile of herbal shampoos Journal of Pharmacognosy and Phytochemistry · 2026
    7. Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024 medRxiv (Cold Spring Harbor Laboratory) · 2024
    8. Teriflunomida and hair disorders Journal of The American Academy of Dermatology · 2017
    9. Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system Andrology · 2024
    10. Safety, tolerability, and PK of topical calcitriol formulation for treatment of chemotherapy-induced alopecia (CIA) in patients receiving taxane-based regimen: Final results. Journal of clinical oncology · 2019
    11. Toxicity assessment of the green Dunaliella salina microalgae Toxicology Reports · 2019 · 20 citations
    12. Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial EClinicalMedicine · 2021 · 6 citations
    13. Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial EClinicalMedicine · 2021 · 3 citations
    14. An assessment of hair loss ameliorating effect of medicinal plant extracts, amino acid and vitamin complex in human subject Korean Journal of Human Ecology · 2012 · 3 citations
    15. 608 A clinical study to test the efficacy of VB1953 in clindamycin non-responder acne patients with antibiotic-resistant P. acnes Journal of Investigative Dermatology · 2019 · 1 citations
    16. Safety and Effectiveness of Juvéderm Ultra Plus Injectable Gel in Correcting Severe Nasolabial Folds in Chinese Subjects Plastic and reconstructive surgery. Global open · 2017 · 13 citations
    17. Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study Journal of Dermatological Treatment · 2026
    18. Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications Advances in Therapy · 2023 · 6 citations
    19. Exploring Quality of Life Among Thyroid Patients in South Indian Communities: A Comprehensive Study International Journal of Pharmaceutical Sciences and Drug Research · 2025
    20. Safety and efficacy of tofacitinib in 97 alopecia areata patients Journal of cosmetic dermatology · 2024
    21. Safety of Whole-Body Abrogation of the TRF1 Shelterin Protein in Wild-Type and Cancer-Prone Mouse Models iScience · 2019 · 5 citations
    22. Dermal safety comparison of 0.05% desonide cream and 1.0% hydrocortisone cream Current Therapeutic Research · 1993 · 2 citations
    23. Safety of food containing 5000 mg of collagen peptide and its effect on hair in health female subjects-a double-blind, placebo controlled study- Aesthetic dermatology · 2008 · 1 citations
    24. Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study 2026
    25. Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study 2026
    26. Authentication of herbs by physiological & morphological studies through HPTLC, ICP-MS, UV Spectroscopy, Genetic Engineering & PCR Universities Journal of Phytochemistry and Ayurvedic Heights · 2025
    27. Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies Journal of clinical medicine · 2024
    28. Safety and efficacy of Trimax‐360 serum in healthy adult subjects with mild to moderate alopecia of scalp Journal of Cosmetic Dermatology · 2022
    29. Safety and Efficacy of Deeply Rooted<sup>®</sup> Nutraceutical for Hair Growth in Women Journal of Cosmetics, Dermatological Sciences and Applications · 2020
    30. DEVELOPMENT AND ASSESSMENT OF NATURAL HAIR DYE IN VARIOUS FORMULATIONS USING HENNA, HIBISCUS, SHIKAKAI, AMLA AND INDIGO: A REVIEW Zenodo (CERN European Organization for Nuclear Research) · 2026